Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Insulin-like growth factor binding proteins in development.

Josef V Silha1, Liam J Murphy

  • 1Department of Physiology, University of Manitoba, Winnipeg, Canada.

Advances in Experimental Medicine and Biology
|December 24, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Insulin-like growth factor-binding protein-3 (IGFBP-3) blocks the effects of asthma by negatively regulating NF-κB signaling through IGFBP-3R-mediated activation of caspases.

The Journal of biological chemistry·2011
Same author

Transglutaminase 2 kinase activity facilitates protein kinase A-induced phosphorylation of retinoblastoma protein.

The Journal of biological chemistry·2007
Same author

Ethnicity, insulin resistance, and inflammatory adipokines in women at high and low risk for vascular disease.

Diabetes care·2007
Same author

Variations in parametrial white adipose tissue mass during the mouse estrous cycle: relationship with the expression of peroxisome proliferator-activated receptor-gamma and retinoic acid receptor-alpha.

Canadian journal of physiology and pharmacology·2006
Same author

Prohibitin binds to C3 and enhances complement activation.

Molecular immunology·2006
Same author

Plasma adipokines and body composition in response to modest dietary manipulations in the mouse.

Obesity (Silver Spring, Md.)·2006

Insulin-like growth factor-binding proteins (IGFBPs) impact growth by controlling insulin-like growth factor (IGF) transport and availability. While their absence can cause growth issues, compensatory mechanisms may mask some effects in knockout mice.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Developmental Biology

Background:

  • Insulin-like growth factor-binding proteins (IGFBPs) are crucial regulators of insulin-like growth factor (IGF) action.
  • IGFBP excess typically inhibits IGF signaling, leading to growth retardation and impaired organogenesis.
  • The absence of IGFBP-1 or Acid Labile Subunit (ALS) results in decreased circulating IGF-I and mild growth retardation.

Purpose of the Study:

  • To investigate the role of IGFBPs in growth and development.
  • To explore potential compensatory mechanisms that may mask phenotypes in IGFBP knockout (KO) models.
  • To examine IGF-independent actions of IGFBPs in vivo.

Main Methods:

  • Analysis of IGFBP knockout (KO) mouse models.
  • Studies involving mutant IGFBP-3 transgenic (Tg) mice.

Related Experiment Videos

  • Investigation of hepatic regeneration processes.

    • Main Results:

    • IGFBP KO mice often exhibit minor phenotypes, suggesting compensatory mechanisms.
    • Absence of ALS leads to reduced IGF-I levels and mild growth retardation.
    • Studies on hepatic regeneration in IGFBP-1 KO and IGFBP-3 Tg mice hint at IGF-independent actions.

    Conclusions:

    • IGFBPs play a significant role in regulating IGF bioavailability and action.
    • Compensatory mechanisms can obscure the full phenotypic impact of individual IGFBP deficiencies.
    • Evidence suggests that IGFBPs may exert some functions independently of IGF signaling in vivo.